Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
Costs of Care and The Leapfrog Group today announced that Jeffrey A. Flaks, President and Chief Executive Officer of Hartford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback